In conclusion, our integrative transcriptomic and immunogenomic analyses define the molecular and immune landscape of ABC DLBCL and identify MAPK10 and CCL18 as potential prognostic biomarkers. Here, MAPK10 is linked to diffuse large B-cell lymphoma.